IMARC Group’s report titled “Digital PCR Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, offers a comprehensive analysis of the industry, which comprises insights on the global digital pcr market report. The global market size reached US$ 4.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2023-2028.
Digital PCR (dPCR) is a highly sensitive molecular biology technique used to quantify and analyze nucleic acids, such as DNA or RNA, in a sample. It partitions the sample into numerous individual reactions, each containing a small number of target molecules. By amplifying and detecting the target molecules within these partitions, dPCR enables precise quantification of the nucleic acids present. This technology offers advantages in terms of its ability to detect rare genetic variants, accurately measure gene expression levels, and provide absolute quantification without the need for external standards. With its high sensitivity and reproducibility, dPCR finds applications in research areas such as genomics, cancer diagnostics, infectious disease detection, and liquid biopsies.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/digital-pcr-market/requestsample
Digital PCR Market Trends and Drivers:
The digital PCR (dPCR) market is driven by various industry trends and drivers that contribute to its growth and expansion. One significant trend is the increasing adoption of precision medicine and personalized diagnostics. dPCR provides a highly sensitive and accurate method for quantifying nucleic acids, making it valuable in detecting and monitoring genetic variations and mutations associated with diseases. This aligns with the growing demand for precise and targeted therapies, driving the uptake of dPCR technology in healthcare. Another driver is the rising prevalence of infectious diseases and genetic disorders. dPCR’s ability to detect and quantify low abundance nucleic acid targets enables early diagnosis and monitoring of diseases, leading to improved patient outcomes. Additionally, the advancements in genomics research and the need for better understanding of genetic variations fuel the demand for dPCR technologies, as they offer higher resolution and sensitivity compared to traditional PCR methods.
The increasing focus on non-invasive liquid biopsies is also driving the market. dPCR plays a crucial role in analyzing and detecting genetic biomarkers present in circulating tumor DNA or cell-free DNA, facilitating early cancer detection, monitoring treatment response, and disease progression. This non-invasive approach is gaining traction as an alternative to invasive tissue biopsies, and dPCR is a key enabling technology in this field.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product Type:
- Digital PCR Equipment
- Consumables and Reagents
- Software and Services
Breakup by Technology:
- Droplet Digital PCR
- BEAMing Digital PCR
Breakup by Application:
- Clinical Diagnostics
- Forensics
- Research
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Avance Biosciences Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- JN Medsys
- OPTOLANE Technologies Inc.
- QIAGEN
- SAGA Diagnostics AB
- Standard BioTools Inc.
- Stilla Technologies
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
